Northern Trust’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,688,021
| Closed | -$125M | – | 4348 |
|
|
2019
Q2 | $125M | Buy |
2,688,021
+31,961
| +1% | +$897K | 0.03% | 496 |
|
|
2019
Q1 | $64.8M | Buy |
2,656,060
+75,458
| +3% | +$1.57M | 0.02% | 774 |
|
|
2018
Q4 | $36.8M | Sell |
2,580,602
-6,115
| -0.2% | -$92.8K | 0.01% | 1083 |
|
|
2018
Q3 | $39.3M | Buy |
2,586,717
+62,053
| +2% | +$951K | 0.01% | 1215 |
|
|
2018
Q2 | $42.4M | Buy |
2,524,664
+105,314
| +4% | +$1.68M | 0.01% | 1162 |
|
|
2018
Q1 | $39.5M | Buy |
2,419,350
+34,658
| +1% | +$555K | 0.01% | 1168 |
|
|
2017
Q4 | $30.5M | Buy |
2,384,692
+264,241
| +12% | +$3.01M | 0.01% | 1382 |
|
|
2017
Q3 | $26.1M | Sell |
2,120,451
-10,042
| -0.5% | -$93.3K | 0.01% | 1513 |
|
|
2017
Q2 | $17.8M | Buy |
2,130,493
+166,031
| +8% | +$1.36M | 0.01% | 1756 |
|
|
2017
Q1 | $17.6M | Buy |
1,964,462
+13,840
| +0.7% | +$147K | 0.01% | 1725 |
|
|
2016
Q4 | $17.1M | Buy |
1,950,622
+381,539
| +24% | +$2.81M | 0.01% | 1711 |
|
|
2016
Q3 | $10.6M | Buy |
1,569,083
+17,284
| +1% | +$66.9K | ﹤0.01% | 2031 |
|
|
2016
Q2 | $5.53M | Sell |
1,551,799
-72,830
| -4% | -$237K | ﹤0.01% | 2389 |
|
|
2016
Q1 | $4.81M | Buy |
1,624,629
+27,004
| +2% | +$80.9K | ﹤0.01% | 2428 |
|
|
2015
Q4 | $6.74M | Buy |
1,597,625
+37,924
| +2% | +$173K | ﹤0.01% | 2268 |
|
|
2015
Q3 | $7.11M | Sell |
1,559,701
-18,061
| -1% | -$107K | ﹤0.01% | 2226 |
|
|
2015
Q2 | $11.4M | Buy |
1,577,762
+116,333
| +8% | +$858K | ﹤0.01% | 1985 |
|
|
2015
Q1 | $10.8M | Buy |
1,461,429
+81,029
| +6% | +$577K | ﹤0.01% | 2032 |
|
|
2014
Q4 | $6.53M | Sell |
1,380,400
-51,782
| -4% | -$205K | ﹤0.01% | 2328 |
|
|
2014
Q3 | $5.11M | Sell |
1,432,182
-50,218
| -3% | -$198K | ﹤0.01% | 2496 |
|
|
2014
Q2 | $6.76M | Sell |
1,482,400
-110,326
| -7% | -$456K | ﹤0.01% | 2320 |
|
|
2014
Q1 | $7.49M | Sell |
1,592,726
-144,979
| -8% | -$729K | ﹤0.01% | 2306 |
|
|
2013
Q4 | $8.71M | Buy |
1,737,705
+109,156
| +7% | +$594K | ﹤0.01% | 2174 |
|
|
2013
Q3 | $10.1M | Sell |
1,628,549
-3,502
| -0.2% | -$20.8K | ﹤0.01% | 2020 |
|
|
2013
Q2 | $7.41M | Buy |
+1,632,051
| New | +$8.78M | ﹤0.01% | 2142 |
|
Other funds holding ARRY
Northern Trust's ARRY Position: Q3 2019 in Review
Northern Trust sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,688,021 shares — an estimated $125M sold.
Northern Trust first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $125M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Northern Trust reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Northern Trust sold 2,688,021 Array Biopharma Inc shares in Q3 2019, an estimated $125M.
- Northern Trust first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
- Northern Trust's Array Biopharma Inc position peaked at $125M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Northern Trust's 13F filing for Q3 2019, filed 13 Nov 2019.